Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

44.12USD
20 Aug 2014
Price Change (% chg)

$0.08 (+0.18%)
Prev Close
$44.04
Open
$43.78
Day's High
$44.36
Day's Low
$43.57
Volume
450,051
Avg. Vol
745,622
52-wk High
$54.25
52-wk Low
$29.36

Search Stocks
FRATES JAMES M
Trading Date Type Shares Traded Price Shares Held
12 Aug 2014 Buy 8,000 $8.55 105,225
12 Aug 2014 Buy 7,000 $14.90 105,225
12 Aug 2014 Sell 15,000 $41.37 105,225
15 Jul 2014 Buy 8,000 $8.55 105,225
15 Jul 2014 Sell 8,000 $46.50 105,225
24 Jun 2014 Sell 7,000 $50.22 48,225
24 Jun 2014 Buy 7,000 $14.90 48,225
10 Jun 2014 Buy 7,000 $14.90 105,225
10 Jun 2014 Sell 7,000 $47.72 105,225
27 May 2014 Sell 1,179 $45.74 105,225
27 May 2014 Buy 2,500 $0.00 105,225
20 May 2014 Buy 3,750 $0.00 103,904
20 May 2014 Sell 1,769 $44.48 103,904
20 May 2014 Buy 7,000 $14.90 103,904
20 May 2014 Sell 7,000 $44.30 103,904
19 May 2014 Sell 1,769 $43.98 103,904
19 May 2014 Buy 3,750 $0.00 103,904
16 May 2014 Buy 4,350 $0.00 99,942
16 May 2014 Sell 2,052 $43.59 99,942
6 May 2014 Sell 1,000 $46.78 97,644
6 May 2014 Buy 5,130 $14.90 97,644
6 May 2014 Buy 1,870 $12.30 97,644
6 May 2014 Sell 6,000 $45.60 97,644
18 Mar 2014 Sell 7,000 $46.84 97,644
18 Mar 2014 Buy 7,000 $12.30 97,644

Institutional Holders

% Shares Owned: 97.30%
# of Holders: 282
Total Shares Held: 141,897,019
3 Mo. Net Change: 3,064,048
# New Positions: 28
# Closed Positions: 29
# Increased Positions: 123
# Reduced Positions: 131
# Net Buyers: -8

Officers & Directors

Name Age Since Current Position

Richard Pops

52 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

51 2011 President

James Frates

47 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

55 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

54 2011 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

Rebecca Peterson

38 Senior Vice President

James Botkin

64 2011 Senior Vice President - Operations

Elliot Ehrich

54 2011 Senior Vice President - Research and Development, Chief Medical Officer

Michael Landine

60 2011 Senior Vice President - Corporate Development

Srdjan Stankovic

56 2013 Senior Vice President - Clinical Development

Mark Stejbach

50 2012 Senior Vice President, Chief Commercial Officer

Peter Norman

2013 Vice President - Government Affairs and Policy

Paul Mitchell

60 2012 Lead Independent Director

Nancy Wysenski

56 2013 Director

David Anstice

65 2011 Independent Director

Floyd Bloom

76 2011 Independent Director

Robert Breyer

69 2011 Independent Director

Wendy Dixon

58 2011 Independent Director

Geraldine Henwood

59 2011 Independent Director
Search Stocks